Recent therapeutic targets in diabetic nephropathy.
Marwa MohsenAhmed A ElberryAlaa Mohamed RabeaMohamed E A AbdelrahimRaghda R S HusseinPublished in: International journal of clinical practice (2021)
In his review, the pathophysiology, clinical manifestations, and lines of treatment of diabetic nephropathy are discussed. In addition, a focus on the clinical role and nephroprotective effects of the emerging therapeutic class, dipeptidyl peptidase IV (DPP-4) inhibitors, is addressed in detail.
Keyphrases